Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim with Chemotherapy in Colorectal Cancer
NCT00094809Phase 2Completed
- Sponsor
- Amgen
- Start
- Feb 2003
- Primary completion
- May 2006
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by Amgen. Started Feb 2003; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00094809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00094809.